US Stock MarketDetailed Quotes

Globus Medical (GMED)

Watchlist

91.340
+1.160+1.29%

Close May 1 16:00 ET

92.218
+0.878+0.96%

Post 19:52 ET

12.39BMarket Cap23.30P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Globus Medical (GMED) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

16.65%2.94B

25.73%826.42M

22.91%769.05M

18.37%745.34M

-1.41%598.12M

60.62%2.52B

6.61%657.29M

63.10%625.71M

115.93%629.69M

119.26%606.67M

Operating revenue

16.65%2.94B

25.73%826.42M

22.91%769.05M

18.37%745.34M

-1.41%598.12M

60.62%2.52B

6.61%657.29M

63.10%625.71M

115.93%629.69M

119.26%606.67M

Cost of revenue

-7.50%957.8M

-0.88%261.11M

-6.65%252.53M

-4.34%248.77M

-19.09%195.4M

88.90%1.04B

-0.77%263.44M

99.80%270.52M

240.04%260.04M

240.96%241.49M

Gross profit

33.51%1.98B

43.53%565.31M

45.42%516.52M

34.34%496.58M

10.28%402.72M

45.43%1.48B

12.19%393.86M

43.08%355.19M

71.82%369.65M

77.39%365.18M

Operating expense

14.19%1.44B

21.33%384M

24.87%381.51M

21.80%373.77M

-9.22%304.66M

54.42%1.26B

-2.78%316.49M

53.30%305.52M

110.23%306.86M

126.62%335.62M

Selling and administrative expenses

20.09%1.18B

25.80%318.48M

30.63%313.6M

26.80%303.62M

-2.36%242.8M

52.42%981.36M

3.27%253.17M

53.68%240.06M

99.43%239.45M

103.14%248.68M

Research and development costs

-10.08%147.25M

8.25%36.16M

7.59%38.07M

5.98%39.95M

-42.27%33.06M

32.05%163.75M

-36.06%33.41M

20.63%35.38M

76.60%37.7M

171.64%57.27M

Depreciation amortization depletion

-0.99%118.19M

-1.85%29.36M

-0.77%29.84M

1.62%30.19M

-2.95%28.8M

133.92%119.37M

6.36%29.91M

118.56%30.08M

553.38%29.71M

544.99%29.68M

-Depreciation and amortization

-0.99%118.19M

-1.85%29.36M

-0.77%29.84M

1.62%30.19M

-2.95%28.8M

133.92%119.37M

6.36%29.91M

118.56%30.08M

553.38%29.71M

544.99%29.68M

Operating profit

144.86%537.19M

134.34%181.31M

171.80%135.01M

95.59%122.81M

231.78%98.06M

8.92%219.39M

203.17%77.37M

1.47%49.67M

-9.24%62.79M

-48.83%29.56M

Net non-operating interest income expense

270.47%7.14M

306.38%3.31M

287.74%1.46M

129.68%693K

188.75%1.68M

-120.81%-4.19M

131.58%815K

-109.79%-775K

-128.15%-2.34M

-129.15%-1.89M

Total other finance cost

-270.47%-7.14M

-306.38%-3.31M

-287.74%-1.46M

-129.68%-693K

-188.75%-1.68M

120.81%4.19M

-131.58%-815K

109.79%775K

128.15%2.34M

129.15%1.89M

Other net income (expense)

164.29%60.74M

71.24%-15.39M

-7.42%7.53M

602.31%64.67M

110.84%3.93M

-68.25%-94.48M

-2,704.23%-53.52M

114.97%8.14M

-359.95%-12.87M

-3,278.73%-36.22M

Gain on sale of security

93.06%-3.01M

80.92%-7.15M

-101.57%-161K

105.41%38K

127.78%4.27M

-403.56%-43.29M

-288.32%-37.49M

293.43%10.28M

-28.28%-703K

-7,350.47%-15.37M

Special income (charges)

212.98%60.33M

49.53%-8.63M

491.04%6.16M

584.95%63.86M

95.10%-1.06M

21.79%-53.4M

-11.03%-17.1M

96.76%-1.57M

-343.82%-13.17M

-1,484.06%-21.56M

-Less：Restructuring and merger&acquisition

-212.98%-60.33M

-49.53%8.63M

-491.04%-6.16M

-584.95%-63.86M

-95.10%1.06M

-21.79%53.4M

9.72%17.1M

-96.55%1.57M

130.73%13.17M

1,484.06%21.56M

-Less:Other special charges

----

-27.65%314K

-225.60%-314K

-123.12%-676K

148.72%1.34M

---31K

Other non- operating income (expenses)

54.78%3.41M

-63.39%391K

369.65%1.54M

-22.57%772K

0.42%713K

203.13%2.21M

143.49%1.07M

-20.00%-570K

39.25%997K

822.08%710K

Income before tax

401.21%605.07M

586.07%169.23M

152.48%143.99M

295.48%188.17M

1,311.36%103.67M

-27.01%120.72M

-1.31%24.67M

2,149.78%57.03M

-36.28%47.58M

-113.54%-8.56M

Income tax

278.85%67.2M

1,658.16%28.64M

381.68%25.03M

-192.74%-14.67M

2,057.39%28.21M

-58.28%17.74M

-118.45%-1.84M

238.06%5.2M

-6.73%15.82M

-110.25%-1.44M

Net income

422.28%537.87M

430.44%140.59M

129.50%118.97M

538.68%202.85M

1,160.31%75.46M

-16.19%102.98M

76.30%26.51M

5,093.99%51.84M

-44.97%31.76M

-114.49%-7.12M

Net income continuous Operations

422.28%537.87M

430.44%140.59M

129.50%118.97M

538.68%202.85M

1,160.31%75.46M

-16.19%102.98M

76.30%26.51M

5,093.99%51.84M

-44.97%31.76M

-114.49%-7.12M

Minority interest income

Net income attributable to the parent company

422.28%537.87M

430.44%140.59M

129.50%118.97M

538.68%202.85M

1,160.31%75.46M

-16.19%102.98M

76.30%26.51M

5,093.99%51.84M

-44.97%31.76M

-114.49%-7.12M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

422.28%537.87M

430.44%140.59M

129.50%118.97M

538.68%202.85M

1,160.31%75.46M

-16.19%102.98M

76.30%26.51M

5,093.99%51.84M

-44.97%31.76M

-114.49%-7.12M

Basic earnings per share

423.68%3.98

452.63%1.05

131.58%0.88

552.17%1.5

1,200.00%0.55

-30.28%0.76

72.73%0.19

3,700.00%0.38

-59.65%0.23

-110.20%-0.05

Diluted earnings per share

422.67%3.92

442.11%1.03

131.58%0.88

547.83%1.49

1,180.00%0.54

-29.91%0.75

72.73%0.19

3,700.00%0.38

-59.65%0.23

-110.42%-0.05

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	16.65%2.94B	25.73%826.42M	22.91%769.05M	18.37%745.34M	-1.41%598.12M	60.62%2.52B	6.61%657.29M	63.10%625.71M	115.93%629.69M	119.26%606.67M
Operating revenue	16.65%2.94B	25.73%826.42M	22.91%769.05M	18.37%745.34M	-1.41%598.12M	60.62%2.52B	6.61%657.29M	63.10%625.71M	115.93%629.69M	119.26%606.67M
Cost of revenue	-7.50%957.8M	-0.88%261.11M	-6.65%252.53M	-4.34%248.77M	-19.09%195.4M	88.90%1.04B	-0.77%263.44M	99.80%270.52M	240.04%260.04M	240.96%241.49M
Gross profit	33.51%1.98B	43.53%565.31M	45.42%516.52M	34.34%496.58M	10.28%402.72M	45.43%1.48B	12.19%393.86M	43.08%355.19M	71.82%369.65M	77.39%365.18M
Operating expense	14.19%1.44B	21.33%384M	24.87%381.51M	21.80%373.77M	-9.22%304.66M	54.42%1.26B	-2.78%316.49M	53.30%305.52M	110.23%306.86M	126.62%335.62M
Selling and administrative expenses	20.09%1.18B	25.80%318.48M	30.63%313.6M	26.80%303.62M	-2.36%242.8M	52.42%981.36M	3.27%253.17M	53.68%240.06M	99.43%239.45M	103.14%248.68M
Research and development costs	-10.08%147.25M	8.25%36.16M	7.59%38.07M	5.98%39.95M	-42.27%33.06M	32.05%163.75M	-36.06%33.41M	20.63%35.38M	76.60%37.7M	171.64%57.27M
Depreciation amortization depletion	-0.99%118.19M	-1.85%29.36M	-0.77%29.84M	1.62%30.19M	-2.95%28.8M	133.92%119.37M	6.36%29.91M	118.56%30.08M	553.38%29.71M	544.99%29.68M
-Depreciation and amortization	-0.99%118.19M	-1.85%29.36M	-0.77%29.84M	1.62%30.19M	-2.95%28.8M	133.92%119.37M	6.36%29.91M	118.56%30.08M	553.38%29.71M	544.99%29.68M
Operating profit	144.86%537.19M	134.34%181.31M	171.80%135.01M	95.59%122.81M	231.78%98.06M	8.92%219.39M	203.17%77.37M	1.47%49.67M	-9.24%62.79M	-48.83%29.56M
Net non-operating interest income expense	270.47%7.14M	306.38%3.31M	287.74%1.46M	129.68%693K	188.75%1.68M	-120.81%-4.19M	131.58%815K	-109.79%-775K	-128.15%-2.34M	-129.15%-1.89M
Total other finance cost	-270.47%-7.14M	-306.38%-3.31M	-287.74%-1.46M	-129.68%-693K	-188.75%-1.68M	120.81%4.19M	-131.58%-815K	109.79%775K	128.15%2.34M	129.15%1.89M
Other net income (expense)	164.29%60.74M	71.24%-15.39M	-7.42%7.53M	602.31%64.67M	110.84%3.93M	-68.25%-94.48M	-2,704.23%-53.52M	114.97%8.14M	-359.95%-12.87M	-3,278.73%-36.22M
Gain on sale of security	93.06%-3.01M	80.92%-7.15M	-101.57%-161K	105.41%38K	127.78%4.27M	-403.56%-43.29M	-288.32%-37.49M	293.43%10.28M	-28.28%-703K	-7,350.47%-15.37M
Special income (charges)	212.98%60.33M	49.53%-8.63M	491.04%6.16M	584.95%63.86M	95.10%-1.06M	21.79%-53.4M	-11.03%-17.1M	96.76%-1.57M	-343.82%-13.17M	-1,484.06%-21.56M
-Less：Restructuring and merger&acquisition	-212.98%-60.33M	-49.53%8.63M	-491.04%-6.16M	-584.95%-63.86M	-95.10%1.06M	-21.79%53.4M	9.72%17.1M	-96.55%1.57M	130.73%13.17M	1,484.06%21.56M
-Less:Other special charges	----	----	----	----	----	-27.65%314K	-225.60%-314K	-123.12%-676K	148.72%1.34M	---31K
Other non- operating income (expenses)	54.78%3.41M	-63.39%391K	369.65%1.54M	-22.57%772K	0.42%713K	203.13%2.21M	143.49%1.07M	-20.00%-570K	39.25%997K	822.08%710K
Income before tax	401.21%605.07M	586.07%169.23M	152.48%143.99M	295.48%188.17M	1,311.36%103.67M	-27.01%120.72M	-1.31%24.67M	2,149.78%57.03M	-36.28%47.58M	-113.54%-8.56M
Income tax	278.85%67.2M	1,658.16%28.64M	381.68%25.03M	-192.74%-14.67M	2,057.39%28.21M	-58.28%17.74M	-118.45%-1.84M	238.06%5.2M	-6.73%15.82M	-110.25%-1.44M
Net income	422.28%537.87M	430.44%140.59M	129.50%118.97M	538.68%202.85M	1,160.31%75.46M	-16.19%102.98M	76.30%26.51M	5,093.99%51.84M	-44.97%31.76M	-114.49%-7.12M
Net income continuous Operations	422.28%537.87M	430.44%140.59M	129.50%118.97M	538.68%202.85M	1,160.31%75.46M	-16.19%102.98M	76.30%26.51M	5,093.99%51.84M	-44.97%31.76M	-114.49%-7.12M
Minority interest income
Net income attributable to the parent company	422.28%537.87M	430.44%140.59M	129.50%118.97M	538.68%202.85M	1,160.31%75.46M	-16.19%102.98M	76.30%26.51M	5,093.99%51.84M	-44.97%31.76M	-114.49%-7.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	422.28%537.87M	430.44%140.59M	129.50%118.97M	538.68%202.85M	1,160.31%75.46M	-16.19%102.98M	76.30%26.51M	5,093.99%51.84M	-44.97%31.76M	-114.49%-7.12M
Basic earnings per share	423.68%3.98	452.63%1.05	131.58%0.88	552.17%1.5	1,200.00%0.55	-30.28%0.76	72.73%0.19	3,700.00%0.38	-59.65%0.23	-110.20%-0.05
Diluted earnings per share	422.67%3.92	442.11%1.03	131.58%0.88	547.83%1.49	1,180.00%0.54	-29.91%0.75	72.73%0.19	3,700.00%0.38	-59.65%0.23	-110.42%-0.05
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm